Download DNB 2019 Dec 2019 Dec SURGICAL GASTROENTEROLOGY PAPER II Question Paper

Download Diplomate in National Board (DNB) 2019 Dec 2019 Dec SURGICAL GASTROENTEROLOGY PAPER II Previous Question Papers

FINAL EXAM NATiONAL BOARD OF EXAMINATIONS
DECEMBER 2019
SURGICAL GASTROENTEROLOGY
PAPER-ll
Time: 3 hours GlS/D/19/46/ll
Max. Marksz100
Important Instructions:
0 Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Stan? the answer to a question on a fresh page or leave adequate space between two answers.
Draw tab/e/diagrams/f/owcharts wherever appropriate.
0 I O l O I 0
Write short notes on:
1. a) Enumerate direct and indirect pancreatic exocrine function. 4+6
b) Discuss role of PERT after Whipple?s Pancreato duodenectomy.
2. a) Classify liver space occupying lesions. 3+7
b) How will you evaluate and treat a patient with Hepatitis B cirrhosis
found to have 1.50m SOL on ultrasound abdomen?
3. a) What is non?seiective shunt? Give two examples. 2+8
b) Discuss the role of shunt surgery in portal hypertension in present
era.
4. 3) Discuss concept of mesopancreas and pancreatic segmentation. 3+1+6
b) Define borderline pancreatic tumours.
c) How will you manage a 45?year-old male with border line
pancreatic head mass with bilirubin 5mg/dl?
5. Compare liver first Vs simultaneous resection in patient with colorectal 10
liver metastasis.
6. Evidence based approach to compare resection Vs transplant in HCC. 10
7. a) How do you Classify surgicalcomplications? 2+3+5
b) What is the importance of classification?
0) What is bench marking as an outcome parameter in surgical
practice and its importance?
8. a) Classify choledochai cysts. 2+2+6
b) Enumerate its complications.
0) How will you evaluate and treat a patient with type 4a choledochai
cyst?
9. a) Recurrent pyogenic cholangitis. 5+5
b) Immuno- suppression in liver transplant.
10. a) Enumerate various tumour markers used in HPB cancer. 3+7
b) Discuss their role in diagnosis and management.
**************
POSSESSION/USE OF CELL PHONES 0R ANYSUCII ELECTRONIC GADGETS IS NOTPERMI?ITED INSIDE THE
le/IMlN/l 7'10N HALL

This post was last modified on 17 April 2020